Author:
Shenge Juliet A.,Osiowy Carla
Abstract
The global health challenge posed by hepatitis B virus (HBV) and hepatitis C virus (HCV) persists, especially in low-and-middle-income countries (LMICs), where underdiagnosis of these viral infections remains a barrier to the elimination target of 2030. HBV and HCV infections are responsible for most liver-related mortality worldwide. Infected individuals are often unaware of their condition and as a result, continue to transmit these viruses. Although conventional diagnostic tests exist, in LMIC they are largely inaccessible due to high costs or a lack of trained personnel, resulting in poor linkage to care and increased infections. Timely and accurate diagnosis is needed to achieve elimination of hepatitis B and C by the year 2030 as set out by the World Health Organization Global Health Sector Strategy. In this review rapid diagnostic tests allowing for quick and cost-effective screening and diagnosis of HBV and HCV, are discussed, as are their features, including suitability, reliability, and applicability in LMIC, particularly those within Africa.
Reference135 articles.
1. Global Health Sector Strategy on Viral Hepatitis2016
2. Global strategies are required to cure and eliminate HBV infection;Revill;Nat Rev Gastroenterol Hepatol.,2016
3. Diagnosis of viral hepatitis;Easterbrook;Curr Opin HIV AIDS.,2017
4. Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer;Ryerson;Cancer.,2016
5. Genetic diversity of hepatitis C virus among blood donors and patients with clinical hepatitis in Ibadan, Nigeria;Shenge;Arch Basic Appl Med.,2018
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献